Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 112 of 144 pages ‹ First < 110 111 112 113 114 > Last ›
HSL960
Masters B.
Painful Withdrawal for Makers of Vioxx: Pulling of Arthritis Drug Raises Questions on Marketing, Safety Risks
The Washington Post 2004 Oct 18
HSL988
Consumers Sue Pharmaceutical AstraZeneca Over Misleading Nexium Campaign - AFL-CIO joins suit alleging scheme to deceive consumers, increase profits
Prescription Access Litigation 2004 Oct 18
HSL989
Hensley S.
Pfizer to Test All-or-Nothing Bet Could Pave Way for Broader Use Of Popular Arthritis Drug
Wall Street Journal 2004 Oct 18
HSL17367
Tindall B
Better Playing Through Chemistry
The New York Times 2004 Oct 17
http://www.nytimes.com/2004/10/17/arts/music/17tind.html?pagewanted=all&position;=
HSL956
Abelson R.
Pfizer Warns of Risks From Its Painkiller
The New York Times 2004 Oct 16
HSL17366
Bowe C
Merck under spotlight for 'deal' with US drug regulators
The Finanical Times 2004 Oct 16
HSL20043
Kmietowicz Z
WMA sets rules on how doctors handle industry sponsorship
BMJ 2004 Oct 16; 329:(876):
http://www.bmj.com//content/329/7471/876.1?variant=full-text
HSL954
Silverman E.
Drug maker promotes generics for workers Novartis draws fire on cost-cutting bid
The Star-Ledger 2004 Oct 15
HSL5473
Mansfield PR.
Reply to Stephen Black and Nicholas DeMartinis
2004 Oct 15; 329:
http://bmj.bmjjournals.com/cgi/eletters/329/7468/748
HSL952
Herper M.
Merck's Missing Vioxx Study
Forbes 2004 Oct 14
HSL19513
Elliott S, Ives N
Questions on the $3.8 Billion Drug Ad Business
The New York Times 2004 Oct 12
http://www.nytimes.com/2004/10/12/business/media/12drug.html?ex=1098610045&ei=1&en=cbf357ef92d96a52
HSL19742
Kassirer J
Outlook: On the Take
The Washington Post 2004 Oct 12
http://www.washingtonpost.com/ac2/wp-dyn/A17496-2004Oct8?language=printer
HSL945
Goar C.
Is drug watchdog on duty for us?
Toronto Star 2004 Oct 11
HSL365
Mansfield PR.
Banned drug's world of faceless victims
The Independent Weekly (Adelaide) 2004 Oct 10-16
HSL5474
Mansfield PR, Tonkin AL, Jureidini JN.
Antidepressants do less good than harm for children and adolescents
BMJ 2004 Oct 8; 329:
http://bmj.bmjjournals.com/cgi/eletters/329/7470/809
HSL19840
McLean B
Pharma breach penalties questioned
Australian Doctor 2004 Oct 8
http://www.australiandoctor.com.au/news/pharma-breach-penalties-questioned
HSL20052
Rayner F
Student ethics code stalled
Australian Doctor 2004 Oct 84
HSL20071
Hope A
Script patterns
Australian Doctor 2004 Oct 823
HSL940
Herper M.
Fuzzy Drug Company Math
Forbes 2004 Oct 5
HSL943
Haskell M.
New law cancels drug benefit Valium, Xanax among Rx cuts
Bangor Daily News 2004 Oct 5
HSL919
Boseley S.
Drugs licensing flaws exposed: Pfizer advised on how to get antidepressant approved by member of body deciding on application
The Guardian 2004 Oct 4
HSL921
Evans R.
The drugs industry and its watchdog: a relationship too close for comfort?
The Guardian 2004 Oct 4
HSL926
Brownlee S.
Mysteries of the Mind
The Washington Post 2004 Oct 4
HSL929
FDA should have required Vioxx safety study years ago, says Vanderbilt professor
SCRIP - World Pharmaceutical News 2004 Oct 4
HSL930
Regulators deal with aftermath of Vioxx withdrawal
SCRIP - World Pharmaceutical News 2004 Oct 4
HSL933
Pollack A.
New Scrutiny of Drugs in Vioxx's Family
New York Times 2004 Oct 4
HSL934
Wilde Mathews A
Vioxx Recall Raises Questions On FDA's Safety Monitoring
The Wall Street Journal 2004 Oct 4
HSL916
Freguson R.
MD deal aims to trim drugs for poor $50M fee hike if $200M in costs cut: Secret accord in tentative Ontario pact
The Toronto Star 2004 Oct 3
HSL880
Topol E.
Good Riddance to a Bad Drug
New York Times 2004 Oct 2
HSL881
Vioxx Withdrawal
ABC RN AM 2004 Oct 2
HSL3802
Benderly BL.
Advocacy groups are crucial players in developing new neurotherapeutics.
NeuroRx 2004 Oct 01; 1:(4):500-2
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=15717051
HSL879
Seaman B.
Treating infertility: Amid a confusing array of resources, how to decide which you can trust
Women's Review of Books 2004 Oct
HSL4759
Bensley RJ, Mercer N, Brusk JJ, Underhile R, Rivas J, Anderson J, Kelleher D, Lupella M, de Jager AC.
The eHealth Behavior Management Model: a stage-based approach to behavior change and management.
Prev Chronic Dis 2004 Oct; 1:(4):A14
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=15670446
HSL4896
Pecoul B.
New drugs for neglected diseases: from pipeline to patients.
PLoS Med 2004 Oct; 1:(1):e6
HSL4937
Gupta AS.
Intellectual capital as property.
Indian J Med Ethics 2004 Oct-Dec; 1:(4):115-6
HSL12935
Carver N, Ashmore R, Rolfe G, Cutcliffe J.
Anything to declare? Competing interests in mental health nursing journals.
Journal of Psychiatric & Mental Health Nursing 2004 Oct-Nov; 11:(5):620-2
http://www.blackwellpublishing.com/journal.asp?ref=1351-0126&site=1
HSL15618
Weinstein J.
Why Advocacy Beats DTC
Pharmaceutical Executive 2004 Oct;
http://www.jweinsteinsm.com/img/PE%20Advoc%20article.pdf
HSL13272
Poor Markets, Rich Rewards: Pharmaceuticals and poor countries
The Economist 2004 Sep 3056
http://www.economist.com/business/displaystory.cfm?story_id=E1_PNVPDDQ
HSL5296
Abdolrasulnia M, Collins BC, Casebeer L, Wall T, Spettell C, Ray MN, Weissman NW, Allison JJ.
Using email reminders to engage physicians in an Internet-based CME intervention.
BMC Med Educ 2004 Sep 29; 4:(17):
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=15453911
HSL878
Faunce T.
It's time - for a bipartisan stand-firm
Sydney Morning Herald 2004 Sep 28
HSL877
Schafer A.
Cracking down on medical trials
The Toronto Star 2004 Sep 27
HSL871
Kanapaux W.
FDA likely to add black box warning for antidepressants
First World 2004 Sep 24
HSL872
Shogren E.
Lawmakers Take FDA to Task on Antidepressants: A House subcommittee says the agency held back data on the drugs' risks to children
LA Times 2004 Sep 24
HSL873
Harris G.
Warnings Called Likely on Drug Risk for Suicide
The New York Times 2004 Sep 24
HSL874
Cohen R.
Regulators deny they covered up suicide info: FDA says antidepressant findings needed scrutiny
STAR-LEDGER 2004 Sep 24
HSL875
Vedantam S.
FDA Told Its Analyst to Censor Data on Antidepressants
The Washington Post 2004 Sep 24
HSL82
Raghavan A, Naik G
A Tie-Up of Aventis, Sanofi Could Create Strong Global Rival
The Wall Street Journal 2004 Sep 23
HSL870
Reuters .
US Reviewer Says Pressured in Antidepressant Probe
The New York Times 2004 Sep 23
HSL351
Cato J.
Pittman defense wants access to drug documents
The Herald 2004 Sep 22
HSL19740
Industry thought leaders critical to marketing success
eyeforpharma.com 2004 Sep 22
http://social.eyeforpharma.com/uncategorised/industry-thought-leaders-critical-marketing-success
HSL3051
Baker D
Financing Drug Research: What Are the Issues?
Washington DC: Center for Economic and Policy Research 2004 Sep 21
http://www.cepr.net/index.php/publications/reports/financing-drug-research-what-are-the-issues/
HSL869
Drug Study Registries Raise Competitive Concerns (for Big Pharma)
Reuters 2004 Sep 20
HSL12691
Smoller JW.
The Etiology and Treatment of Childhood
New Media Explorer 2004 Sep 19
http://www.newmediaexplorer.org/emma_holister/2004/09/19/the_etiology_and_treatment_of.htm
HSL868
Tenpenny S.
Vaccines: An Online Conference: The Flu Season Campaign Begins
Redflagsdaily.com 2004 Sep 17
HSL20069
Marshal T
Hijacked by ads
Australian Doctor 2004 Sep 1719
HSL867
Tell Truth About Antidepressants: On drug labels and in medical journals
Newsday.com 2004 Sep 16
HSL866
For Honest Reports of Drug Trials
The New York Times 2004 Sep 11
HSL876
Meet the people shaping the future of science: Cures before cash
Interview New Scientist 2004 Sep 4
HSL20079
Sweeney C
Expert calls for advertising ban on prescribing software
Australian Doctor 2004 Sep 35
http://www.australiandoctor.com.au/news/latest-news/expert-calls-for-advertising-ban-on-prescribing-so
HSL865
Vranica S.
Drug Maker, Talent Agency Team Up to Place Product In Entertainment Venues
The Wall Street Journal 2004 Sep 2
HSL863
Miller H.
The Truth About Marcia Angell
Tech Central Station 2004 Sep 1
HSL864
Cassels A.
We can swing no-frills Pharmacare
Vancouver Sun 2004 Sep 1
HSL4449
Saunders C.
Program targets drug rep input.
Australian Doctor Weekly 2004 Sep 1
HSL5329
Elliott C.
Pharma goes to the laundry: Public relations and the business of medical education.
Hastings Cent Rep 2004 Sep-Oct 01; 34:(5):18-23
HSL1790
Andrews E, Dombeck M.
The role of scientific evidence of risks and benefits in determining risk management policies for medications.
Pharmacoepidemiol Drug Saf 2004 Sep; 13:(9):599-608
http://www3.interscience.wiley.com/cgi-bin/abstract/105560406/ABSTRACT
HSL2414
Donohue JM, Berndt ER.
Effects of Direct-to-Consumer Advertising on Medication Choice: The Case of Antidepressants
Journal of Public Policy & Marketing 2004 Fall; 23:(2):115–127
http://www.kff.org/rxdrugs/upload/Effects-of-Direct-to-Consumer-Advertising-on-Medication-Choice-the-Case-of-Antidepressants.pdf
HSL4604
Oldani MJ.
Thick prescriptions: toward an interpretation of pharmaceutical sales practices.
Med Anthropol Q 2004 Sep; 18:(3):325-56
HSL13270
Druss BG, Marcus SC, Olfson M, Pincus HA.
Listening to generic Prozac: winners, losers, and sideliners.
Health Aff (Millwood) 2004 Sep-Oct; 23:(5):210-6
http://content.healthaffairs.org/cgi/content/full/23/5/210
HSL13302
Oldani MJ.
Thick prescriptions: toward an interpretation of pharmaceutical sales practices.
Med Anthropol Q 2004 Sep; 18:(3):325-56
http://www.ncbi.nlm.nih.gov/pubmed/15484967
HSL13310
Vatjanapukka V, Waryszak R.
Relationship between consumer knowledge, prescription drug advertising exposure and attitudes towards direct-to-consumer prescription drug advertising
International Journal of Medical Marketing 2004 Sep; 4:(4):350-360
http://www.ingentaconnect.com/content/pal/jmm/2004/00000004/00000004/art00010
HSL511
Martinez B.
Merck Dealt Setback by Zocor Study: In Cholesterol-Drug Battle, Large-Dose Regime Failed To Help High-Risk Patients
Wall Street Journal 2004 Aug 31
HSL509
Vergano D.
Scientists want research papers freely available
USA TODAY 2004 Aug 29
http://www.usatoday.com/news/science/2004-08-29-free-research_x.htm
HSL510
Day M.
Doctors' body accuses drug firms of 'disease mongering'
The Daily Telegraph 2004 Aug 29
HSL507
Mathews A.
Big HMO Reconsiders Vioxx After Study Points to Heart Risks
The Wall Street Journal 2004 Aug 26
HSL508
Quiggin J.
Labor must stand firm
Australian Financial Review 2004 Aug 26
HSL20001
Scherer FM
The Pharmaceutical Industry — Prices and Progress
NEJM 2004 Aug 26; 351:927-932
http://www.nejm.org/doi/full/10.1056/NEJMhpr040117
HSL503
Pharmaceutical Drug Marketing Budgets Surpass $500 Million, Studies Show
PRNewswire 2004 Aug 25
HSL504
Allen L.
Gillard's $1bn plan for drugs
Australian Financial Review 2004 Aug 25
HSL505
Top U.S. Newspaper's Focous On Balance Skewed Coverage Of Global Warming, Analysis Reveals
2004 Aug 25
HSL502
Ipsos: Branded drug prices spurring non-compliance
Eyeforpharma 2004 Aug 24
HSL498
Roberts P.
Biota votes Australia best for research
Australian Financial Review 2004 Aug 23
HSL499
A marvel of modern medicine, and more
The Melbourne Age 2004 Aug 23
HSL500
Bremmer I.
To fight terrorism 'drug', US needs a demand-side strategy
The Australian 2004 Aug 23
HSL501
Bremmer .
To fight terrorism 'drug', US needs a demand-side strategy
The Australian 2004 Aug 23
HSL497
Gellene D.
'Mr. Botox' Case Raises Some Brows
LA Times 2004 Aug 22
HSL493
Mathews J, Thurbon E.
Bitter pill for an appendage state
2004 Aug 20
HSL494
Maine Inmate Sues OxyContin Maker
Join Together Online 2004 Aug 20
HSL496
Moss L.
Call to monitor drugs as antidepressants kill 500 people a year
Independent News 2004 Aug 20
HSL492
Angell M.
Drugmakers "Blackmail the Public"
Business Week 2004 Aug 18
HSL491
Harrison J.
OxyContin maker sued by state prison inmate
Bangor Daily News 2004 Aug 17
HSL19831
Simmonds HJ
Association of British Pharmaceutical Industry's code of practice needs to be clarified
BMJ 2004 Aug 14; 329:(7462):404
http://www.bmj.com/content/329/7462/404.2.short
HSL20198
Rouse R
New Zealand voice raises risks of DTC advertising
Medical Observer 2004 Aug 145
HSL19841
Rouse R
New code seeks clearer promotion of drug benefits
Medical Observer 2004 Aug 13
HSL19956
Smith P
Drug compang ad rebunked by TGA
Australian Doctor 2004 Aug 133
http://www.australiandoctor.com.au/news/drug-company-ad-rebuked-by-tga
HSL979
Moyers B.
Media That Set Us Free
YES! Magazine 2004 Aug 11
HSL1607
Mansfield PR.
A 5 minute read re drug promotion: RCT
Poster presented at 8th World Congress on Clinical Pharmacology & Therapeutics (CPT2004) Brisbane 2004 Aug 1-6;
HSL4957
Phillips GC.
Medicolegal issues and ergogenic aids: trade, tragedy, and public safety, the example of ephedra and the Dietary Supplement Health and Education Act.
Curr Sports Med Rep 2004 Aug 01; 3:(4):224-8
HSL9040
Halperin EC, Hutchison P, Barrier RC Jr.
A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers.
Int J Radiat Oncol Biol Phys 2004 Aug 1; 59:(5):1477-83
http://linkinghub.elsevier.com/retrieve/pii/S0360301604002639
HSL1804
Reist D, Vandecreek L.
The pharmaceutical industry's use of gifts and educational events to influence prescription practices: Ethical dilemmas and implications for psychologists
Professional psychology-research and practice 2004 Aug; 35:(4):329-335
HSL8662
Leading Clinician Calls for New Approach to Atopic Eczema Treatment at International Gathering of Patients’ Groups
World Allergy Organization 2004 Aug
http://web.archive.org/web/20070626193215/http://www.worldallergy.org/media/press_releases/atopic_eczema.html
Page 112 of 144 pages ‹ First < 110 111 112 113 114 > Last ›
